This blog post was written by Deniz Temelli, Business Analyst at TechAlliance. Late last fall genetics testing company 23andMe was ordered to stop marketing and selling their Personal Genome Service by the FDA (recap in my last blog post here). The company soon complied and limited their services to providing only ancestry related information. However,…
This blog post was written by Deniz Temelli, Business Analyst at TechAlliance. Early last December, the Google-backed personal genetics company 23andMe was ordered to stop marketing and selling its Personal Genome Service by the FDA. You can read the details of why in my last blog post. The fall out and debate surrounding this decision…
This blog post was written by Deniz Temelli, Business Analyst at TechAlliance. Early last week, the FDA sent Google-backed genetics testing company 23andMe a letter ordering them to halt sales and marketing of their Personal Genome Service (PGS). As part of this service, a customer sends the company a saliva sample from which 900,000 base…